BIOCARE COPENHAGEN A/S
CVR number: 34202982
Kirkebjerg Allé 88, 2605 Brøndby
tel: 70200506
www.biocarecph.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 25 763.00 | 29 850.00 | 28 310.00 | 24 429.00 | 23 720.00 |
Employee benefit expenses | -5 889.00 | -5 072.00 | -4 232.00 | ||
Total depreciation | - 181.00 | - 182.00 | - 149.00 | ||
EBIT | 18 904.00 | 23 317.00 | 22 241.00 | 19 175.00 | 19 339.00 |
Other financial income | 46.00 | 970.00 | |||
Other financial expenses | - 178.00 | - 553.00 | -1 552.00 | ||
Pre-tax profit | 14 597.00 | 17 978.00 | 22 063.00 | 18 668.00 | 18 757.00 |
Income taxes | -4 971.00 | -4 154.00 | -4 129.00 | ||
Net earnings | 14 597.00 | 17 978.00 | 17 092.00 | 14 514.00 | 14 628.00 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Development expenditure | 330.00 | 193.00 | 96.00 | ||
Intangible assets total | 330.00 | 193.00 | 96.00 | ||
Machinery and equipment | 135.00 | 213.00 | 160.00 | ||
Tangible assets total | 135.00 | 213.00 | 160.00 | ||
Other receivables | 68 082.00 | 55 285.00 | -1.00 | ||
Investments total | 68 082.00 | 55 285.00 | -1.00 | ||
Long term receivables total | |||||
Semifinished products | 3 200.00 | 2 811.00 | 6 364.00 | ||
Raw materials and consumables | 5 782.00 | 7 305.00 | 7 774.00 | ||
Finished products/goods | 984.00 | 114.00 | 264.00 | ||
Inventories total | 9 966.00 | 10 230.00 | 14 402.00 | ||
Current trade debtors | 19 324.00 | 22 765.00 | 12 613.00 | ||
Current amounts owed by group member comp. | 6 946.00 | 950.00 | 9 993.00 | ||
Prepayments and accrued income | 48.00 | 60.00 | |||
Current other receivables | 529.00 | 482.00 | 251.00 | ||
Short term receivables total | 26 799.00 | 24 245.00 | 22 917.00 | ||
Cash and bank deposits | 12 487.00 | 11 496.00 | 3 319.00 | ||
Cash and cash equivalents | 12 487.00 | 11 496.00 | 3 319.00 | ||
Balance sheet total (assets) | 68 082.00 | 55 285.00 | 49 716.00 | 46 377.00 | 40 894.00 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 47 359.00 | 35 337.00 | 500.00 | 500.00 | 500.00 |
Shares repurchased | 28 000.00 | 15 000.00 | 14 000.00 | ||
Other reserves | 257.00 | 150.00 | 75.00 | ||
Retained earnings | -14 597.00 | -17 978.00 | -16 420.00 | -14 221.00 | -13 632.00 |
Profit of the financial year | 14 597.00 | 17 978.00 | 17 092.00 | 14 514.00 | 14 628.00 |
Shareholders equity total | 47 359.00 | 35 337.00 | 29 429.00 | 15 943.00 | 15 571.00 |
Provisions | 82.00 | 54.00 | 30.00 | ||
Non-current liabilities total | |||||
Advances received | 450.00 | 1 014.00 | 1 172.00 | ||
Current trade creditors | 12 924.00 | 10 281.00 | 15 297.00 | ||
Current owed to participating | 4 183.00 | 4 153.00 | |||
Current owed to group member | 229.00 | 14 127.00 | 4 239.00 | ||
Short-term deferred tax liabilities | 4 883.00 | ||||
Other non-interest bearing current liabilities | 1 719.00 | 775.00 | 432.00 | ||
Current liabilities total | 20 205.00 | 30 380.00 | 25 293.00 | ||
Balance sheet total (liabilities) | 47 359.00 | 35 337.00 | 49 716.00 | 46 377.00 | 40 894.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.